Zobrazeno 1 - 10
of 2 472
pro vyhledávání: '"THROMBOEMBOLIC EVENTS"'
Publikováno v:
Journal of Inflammation Research, Vol Volume 17, Pp 9539-9547 (2024)
Liubing Li,1,* Tangdan Ding,1,2,* Qiong Shi,1,* Hongji Zhu,1,2 Qinghua Ma,1,2 Mianjing Zhou,3 Ying Yuan,4 Zhihua Wen,5 Hongxu Xu,1,2 Hongxia Tan,1 Dubo Chen1 1Department of Laboratory Medicine, The First Affiliated Hospital, Sun Yat-Sen U
Externí odkaz:
https://doaj.org/article/0d592a59008a4bffb4862154b3f535cd
Publikováno v:
Risk Management and Healthcare Policy, Vol Volume 17, Pp 2587-2598 (2024)
Peng Liu,1,2,* Tingting Lv,1,* Yuanwei Liu,1,* Xiaofei Zhang,1 Fei She,1 Rong He,1 Dan Li,1 Lianfeng Liu,1 Ping Zhang1 1Department of Cardiology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua University, Beiji
Externí odkaz:
https://doaj.org/article/a657980898c74a5dbde5979821abe3c8
Publikováno v:
The Egyptian Heart Journal, Vol 76, Iss 1, Pp 1-11 (2024)
Abstract Background Arterial or venous thromboembolic events are responsible for one-fourth of all deaths worldwide. Anticoagulants are the mainstay for the prevention and treatment of venous thromboembolic events (VTE). Heparin and vitamin K antagon
Externí odkaz:
https://doaj.org/article/4782368012874044888b15bf2728de29
Publikováno v:
BMC Nephrology, Vol 25, Iss 1, Pp 1-7 (2024)
Abstract Background Low albumin level is a risk factor for thromboembolic events in patients with NS (nephrotic syndrome). However, little is known about the proportion and characteristics of patients with NS who experience thromboembolic events with
Externí odkaz:
https://doaj.org/article/538b1fa0dd8c40d2b13b391a503fccb2
Autor:
Tua Gyldenholm, Nina Madsen, Niels Katballe, Daniel Willy Kjær, Thomas Decker Christensen, Anne-Mette Hvas
Publikováno v:
Trials, Vol 25, Iss 1, Pp 1-9 (2024)
Abstract Background The purpose of the study is to examine if prolonged thromboprophylaxis decreases the risk of thrombosis after intended curative surgery for oesophageal cancer. Study results are expected to inform a guideline for thromboprophylaxi
Externí odkaz:
https://doaj.org/article/4f5c52e7d2c9473bb644ce8c82ff5b33
Autor:
Jiefeng Ren, Haijun Wang, Song Lai, Yi Shao, Hebin Che, Zaiyao Xue, Xinlian Qi, Sha Zhang, Jinkun Dai, Sai Wang, Kunlian Li, Wei Gan, Quanjin Si
Publikováno v:
BMC Cardiovascular Disorders, Vol 24, Iss 1, Pp 1-9 (2024)
Abstract Objective Accurate prediction of survival prognosis is helpful to guide clinical decision-making. The aim of this study was to develop a model using machine learning techniques to predict the occurrence of composite thromboembolic events (CT
Externí odkaz:
https://doaj.org/article/a9cbfd5b640b48c586dca0423a0989bb
Autor:
Jun Zhang, Lili Zhou, Zhongyuan Ren, Shiyu Feng, Jiayu Wu, Haotian Yang, Yixing Zheng, Weilun Meng, Yang Su, Jun Xu, Hui Sun, Yifan Zhao, Yun Xie, Yawei Xu, Dongdong Zhao
Publikováno v:
Heliyon, Vol 10, Iss 17, Pp e36647- (2024)
Background: Left atrial appendage closure (LAAC) was effective in preventing thromboembolic events and stroke in patients with atrial fibrillation (AF). However, whether left atrial spontaneous echo contrast (LA-SEC) poses a higher risk for thromboem
Externí odkaz:
https://doaj.org/article/822be3557ea54ee1908627f63e3947c7
Autor:
Lucie Miksová, Vladimír Dytrych, Václav Ptáčník, Martin Balík, Aleš Linhart, Jan Bělohlávek, Pavel Jansa
Publikováno v:
Pulmonary Circulation, Vol 14, Iss 3, Pp n/a-n/a (2024)
Abstract COVID‐19 associates with a hypercoagulant state and an increased risk for venous thromboembolic events (VTEs). Whether severe COVID‐19 infection requiring extracorporeal membrane oxygenation (ECMO) support might lead to chronic pulmonary
Externí odkaz:
https://doaj.org/article/f5a36ebc2ffd479c92149ed19a381d24
Autor:
Gliceida Galarza Fortuna, Beverly Chigarira, Vinay Mathew Thomas, Kamal Kant Sahu, Shruti Adidam Kumar, Nishita Tripathi, Nicolas Sayegh, Neeraj Agarwal, Umang Swami, Benjamin L. Maughan, Haoran Li
Publikováno v:
Journal of Kidney Cancer and VHL, Vol 11, Iss 3 (2024)
Thromboembolic events (TE) are a common complication in patients with metastatic renal cell carcinoma (mRCC) and are associated with poorer clinical outcomes. However, the incidence of TE and clinical and genomic characteristics of patients with mRCC
Externí odkaz:
https://doaj.org/article/3d723b5354184447bddff64aa213d2b4
Autor:
Zhen-Tao Fei, Peng-Cheng Yao, Mu Chen, Yu-Dong Fei, Wei Li, Peng-Pai Zhang, Jian Sun, Qun-Shan Wang, Yi-Gang Li
Publikováno v:
Heliyon, Vol 10, Iss 12, Pp e32516- (2024)
Background: Many patients with atrial fibrillation (AF) discontinued oral anticoagulation (OAC) therapy after successful catheter ablation. We aimed to determine the real-world risks and consequences of discontinuing OAC use after catheter ablation f
Externí odkaz:
https://doaj.org/article/ec8ef0a695464a18b638f3d03986929a